Negative regulation of Gq-mediated pathways in platelets by G(12/13) pathways through Fyn kinase

Area of Science:

• Hematology
• Molecular Biology
• Cell Signaling

Background:

• Platelets are crucial for hemostasis and thrombosis.
• Src family kinases (SFKs) are abundant in platelets.
• The precise role of SFKs in G protein-mediated platelet signaling remains unclear.

Purpose of the Study:

• To elucidate the functional role of SFKs downstream of G protein pathways in platelet activation.
• To investigate the involvement of SFKs as negative regulators in platelet responses.
• To identify specific SFKs and G protein pathways involved in platelet modulation.

Main Methods:

• Utilized SFK inhibitors (e.g., PP2) and G protein-selective inhibitors (e.g., YM254890).
• Assessed platelet shape change, aggregation, secretion, and intracellular calcium mobilization.
• Examined protein kinase C (PKC) activation.
• Employed G(q)-deficient and Fyn/Lyn-deficient mouse models.

Main Results:

• SFK inhibition potentiated G(12/13)-mediated platelet activation, including shape change, aggregation, secretion, and calcium mobilization.
• SFKs act as negative regulators downstream of G(12/13) but not G(q)/G(i) pathways.
• SFKs negatively regulate platelet responses via modulation of G(q) pathways, impacting calcium and PKC activation.
• Fyn deficiency, but not Lyn deficiency, potentiated platelet aggregation and PKC activation.

Conclusions:

• SFKs, particularly Fyn, activated downstream of G(12/13) pathways negatively regulate platelet responses.
• This negative regulation occurs through the inhibition of intracellular calcium mobilization and PKC activation via G(q) pathways.
• Findings reveal a novel regulatory mechanism in platelet signaling involving SFKs and G protein pathways.